These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 24806207)
1. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells. Jiang F; Mu J; Wang X; Ye X; Si L; Ning S; Li Z; Li Y PLoS One; 2014; 9(5):e96698. PubMed ID: 24806207 [TBL] [Abstract][Full Text] [Related]
2. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling. Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal. Li Y; Jiang F; Liu Q; Shen J; Wang X; Li Z; Zhang J; Lu X Toxicol Sci; 2015 Jan; 143(1):156-64. PubMed ID: 25304214 [TBL] [Abstract][Full Text] [Related]
4. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells. Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803 [TBL] [Abstract][Full Text] [Related]
5. Blockage of TGFβ-SMAD2 by demethylation-activated miR-148a is involved in caffeic acid-induced inhibition of cancer stem cell-like properties in vitro and in vivo. Li Y; Jiang F; Chen L; Yang Y; Cao S; Ye Y; Wang X; Mu J; Li Z; Li L FEBS Open Bio; 2015; 5():466-75. PubMed ID: 26106521 [TBL] [Abstract][Full Text] [Related]
6. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma. Yan H; Dong X; Zhong X; Ye J; Zhou Y; Yang X; Shen J; Zhang J Mol Carcinog; 2014 Dec; 53(12):960-9. PubMed ID: 23861222 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner. Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934 [TBL] [Abstract][Full Text] [Related]
8. MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT. Yang X; Ye J; Yan H; Tang Z; Shen J; Zhang J; Yang L Tumour Biol; 2016 Jan; 37(1):201-9. PubMed ID: 26188902 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641 [TBL] [Abstract][Full Text] [Related]
10. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells. Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer. Ji H; Li Y; Jiang F; Wang X; Zhang J; Shen J; Yang X Cancer Sci; 2014 Dec; 105(12):1541-9. PubMed ID: 25283513 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-181a-5p suppresses cell proliferation by targeting Egr1 and inhibiting Egr1/TGF-β/Smad pathway in hepatocellular carcinoma. Bi JG; Zheng JF; Li Q; Bao SY; Yu XF; Xu P; Liao CX Int J Biochem Cell Biol; 2019 Jan; 106():107-116. PubMed ID: 30503931 [TBL] [Abstract][Full Text] [Related]
13. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells. Shi L; Xi J; Xu X; Peng B; Zhang B Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544 [TBL] [Abstract][Full Text] [Related]
14. miR-494 induces EndMT and promotes the development of HCC (Hepatocellular Carcinoma) by targeting SIRT3/TGF-β/SMAD signaling pathway. Zhang J; Zhu Y; Hu L; Yan F; Chen J Sci Rep; 2019 May; 9(1):7213. PubMed ID: 31076630 [TBL] [Abstract][Full Text] [Related]
15. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells. Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908 [TBL] [Abstract][Full Text] [Related]
16. miR-4458 inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing the TGF-β signaling pathway via targeting TGFBR1. Zhang Y; Shi K; Liu H; Chen W; Luo Y; Wei X; Wu Z Acta Biochim Biophys Sin (Shanghai); 2020 May; 52(5):554-562. PubMed ID: 32324847 [TBL] [Abstract][Full Text] [Related]
17. Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3β/β-catenin signalling. Liu F; Wu X; Jiang X; Qian Y; Gao J J Exp Clin Cancer Res; 2018 Jun; 37(1):122. PubMed ID: 29940988 [TBL] [Abstract][Full Text] [Related]
18. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells. Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128 [TBL] [Abstract][Full Text] [Related]
19. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells. Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527 [TBL] [Abstract][Full Text] [Related]
20. Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p. Li X; Wang L; Cao X; Zhou L; Xu C; Cui Y; Qiu Y; Cao J Toxicol Appl Pharmacol; 2020 Jun; 396():114998. PubMed ID: 32268151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]